CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/22
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23
A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:  Li, Xinghui;  Shen, Jinwen;  Xia, Fan;  Zhu, Ji
收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23
Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:  Wei, Hangping;  Mao, Jie;  Wu, Yandan;  Zhou, Qinfei
收藏  |  浏览/下载：35/0  |  提交时间：2022/02/14
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling
收藏  |  浏览/下载：46/0  |  提交时间：2021/11/01
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin
收藏  |  浏览/下载：43/0  |  提交时间：2021/11/01
Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10
Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载：27/0  |  提交时间：2022/01/10

©版权所有 ©2017 CSpace - Powered by CSpace